Page 151 - NobleCon21

SeaStar Medical Holding Corporation

SELECTED FINANCIAL ITEMS ICU
(in millions of USD)
CQ4 '24 CQ1 '25 CQ2 '25 CQ3 '25 LTM
Income Statement Key Items
Total Revenue 0.07 0.29 0.34 0.18 0.88
Gross Profit 0.07 0.29 0.31 0.17 0.84
Gross Margin 100% 100% 92% 92% 95%
EBIT (4.77) (3.82) (1.76) (3.58) (13.92)
EBIT Margin -7115% -1304% -520% -1956% -1580%
Net Income to Common Shareholders (4.42) (3.77) (2.00) (3.47) (13.67)
Net Margin -6596% -1287% -592% -1897% -1551%

Balance Sheet Key Items
Total Assets 4.66 7.60 8.38 15.53 15.53
Cash & Short Term Investments 1.82 5.30 6.30 13.76 13.76
% of Assets 39% 70% 75% 89% 89%
Current Assets -Total 3.77 6.78 7.65 14.87 14.87
% of Assets 81% 89% 91% 96% 96%
Total Liabilities 6.84 7.03 5.04 4.07 4.07
% of Assets 147% 93% 60% 26% 26%
Current Liabilities - Total 6.84 7.03 5.04 4.07 4.07
% of Assets 147% 93% 60% 26% 26%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity (2.18) 0.57 3.34 11.46 11.46
% of Assets -47% 7% 40% 74% 74%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (4.69) (2.65) (3.01) (3.84) (14.20)
Net Cash Flow - Investing NA NA NA NA 0.00
Net Cash Flow - Financing 4.43 6.13 4.01 11.31 25.88

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference